AU2003259074A8 - Gal3 antagonists for the treatment of neuropathic pain - Google Patents
Gal3 antagonists for the treatment of neuropathic painInfo
- Publication number
- AU2003259074A8 AU2003259074A8 AU2003259074A AU2003259074A AU2003259074A8 AU 2003259074 A8 AU2003259074 A8 AU 2003259074A8 AU 2003259074 A AU2003259074 A AU 2003259074A AU 2003259074 A AU2003259074 A AU 2003259074A AU 2003259074 A8 AU2003259074 A8 AU 2003259074A8
- Authority
- AU
- Australia
- Prior art keywords
- treatment
- neuropathic pain
- gal3
- antagonists
- gal3 antagonists
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04M—TELEPHONIC COMMUNICATION
- H04M3/00—Automatic or semi-automatic exchanges
- H04M3/22—Arrangements for supervision, monitoring or testing
- H04M3/2281—Call monitoring, e.g. for law enforcement purposes; Call tracing; Detection or prevention of malicious calls
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Computer Security & Cryptography (AREA)
- Technology Law (AREA)
- Signal Processing (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21526702A | 2002-08-07 | 2002-08-07 | |
US10/215,267 | 2002-08-07 | ||
PCT/US2003/024869 WO2004014307A2 (en) | 2002-08-07 | 2003-08-07 | Gal3 antagonists for the treatment of neuropathic pain |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003259074A8 true AU2003259074A8 (en) | 2004-02-25 |
AU2003259074A1 AU2003259074A1 (en) | 2004-02-25 |
Family
ID=31714268
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003259074A Abandoned AU2003259074A1 (en) | 2002-08-07 | 2003-08-07 | Gal3 antagonists for the treatment of neuropathic pain |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003259074A1 (en) |
WO (1) | WO2004014307A2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7642281B2 (en) | 2002-08-07 | 2010-01-05 | Helicon Therapeutics, Inc. | Indolone compounds useful to treat cognitive impairment |
GB0323137D0 (en) | 2003-10-03 | 2003-11-05 | Chang Lisa C W | 2,4,6- Trisubstituted pyrimidines and their different uses |
JP2008523152A (en) * | 2004-12-13 | 2008-07-03 | ニューロジェン・コーポレーション | Piperazinyl-pyridine analogues |
CN101378750B (en) * | 2005-12-09 | 2012-07-18 | 海利空医疗公司 | Indolone compounds useful to treat cognitive impairment |
US8277842B1 (en) | 2012-01-20 | 2012-10-02 | Dart Neuroscience (Cayman) Ltd. | Enteric-coated HT-2157 compositions and methods of their use |
CN103006642B (en) * | 2013-01-04 | 2014-10-22 | 中国药科大学 | Application of alkyne methylene indole-2-one derivative |
JP6507157B2 (en) * | 2013-10-07 | 2019-04-24 | カドモン コーポレイション,リミティド ライアビリティ カンパニー | RHO kinase inhibitor |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030078271A1 (en) * | 2001-01-31 | 2003-04-24 | Blackburn Thomas P. | Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
-
2003
- 2003-08-07 WO PCT/US2003/024869 patent/WO2004014307A2/en not_active Application Discontinuation
- 2003-08-07 AU AU2003259074A patent/AU2003259074A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2004014307A3 (en) | 2004-12-29 |
AU2003259074A1 (en) | 2004-02-25 |
WO2004014307A2 (en) | 2004-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS2200036I1 (en) | Use of dihydroimidazolones for the treatment of dogs | |
HK1079426A1 (en) | Use of ikappab kinase inhibitors for the treatment of pain | |
IL161041A0 (en) | Mch antagonists for the treatment of obesity | |
AU2003290605A8 (en) | Compositions and methods for the diagnosis and treatment of sepsis | |
AU2003290059A8 (en) | Use of cd137 antagonists for the treatment of tumors | |
AP2005003336A0 (en) | Combination for the treatment of ADHD | |
AU2003279841A8 (en) | Uses of human zven antagonists | |
GB0213869D0 (en) | The treatment of pain | |
IL175574A0 (en) | Biomarkers for the efficacy of somatostatin analogue treatment | |
AU2003259074A8 (en) | Gal3 antagonists for the treatment of neuropathic pain | |
AU2003242614A8 (en) | Method for the preparation of halogenated benzonitriles | |
GB0330049D0 (en) | The treatment of neuropathic pain conditions | |
HK1087026A1 (en) | Use of indazole derivtives for the treatment of neuropathic pain | |
EP1687275A4 (en) | Pyridin-4-ylamine compounds useful in the treatment of neuropathic pain | |
AU2003259759A1 (en) | Gal3 receptor antagonists for the treatment of affective disorders | |
IL164951A0 (en) | The treatment of pain with lfendropil | |
AU2003238466A8 (en) | Device for the compression of materials | |
AU2003240174A8 (en) | Compositions for the treatment of edematous-firbrosclerotic panniculopathy | |
HK1087027A1 (en) | Use of 2H-Ä1, 3Ü-oxazinoÄ3,2-AÜindole derivatives for the treatment of neuropathic pain | |
GB0216968D0 (en) | Monitor | |
AU2002366272A8 (en) | Edg-receptor agonist for the treatment of hypertension | |
GB0219706D0 (en) | The treatment of neuropathic pain | |
GB0322015D0 (en) | The treatment of neuropathic pain conditions | |
GB0325957D0 (en) | The treatment of pain | |
GB0213870D0 (en) | The treatment of pain conditions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |